XML 72 R58.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and Contingencies (Details) $ in Millions | 3 Months Ended
--- | ---
Mar. 31, 2023 USD ($)
Maximum Net Sales Threshold As Basis For Payment Of Future Contingent Royalties | $ 1.5
Net sales earned relating to payment of future contingent royalties | 0.0
Non-cancelable commitments for product manufacturing costs | 5.5
Agreement With LGM Pharma, LLC |
Purchase Commitment, Remaining Minimum Amount Committed | $ 2.7

X
- Definition The maximum net sales amount that is used as the basis in determining the payment of future contingent royalties. + References No definition available. + Details
Name: | lqda_MaximumNetSalesThresholdAsBasisForPaymentOfFutureContingentRoyalties
Namespace Prefix: | lqda_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of net sales earned by the entity relating to payment of future contingent royalties. + References No definition available. + Details
Name: | lqda_NetSalesEarnedRelatingToPaymentOfFutureContingentRoyalties
Namespace Prefix: | lqda_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of non-cancelable future commitments for product manufacturing costs. + References No definition available. + Details
Name: | lqda_NonCancelableFutureCommitmentForProductManufacturingCosts
Namespace Prefix: | lqda_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(17)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(19)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(25)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=lqda_AgreementWithLGMPharmaLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |